Brain Cancer

Early Radiotherapy Preserves Vision in Certain Children With Glioma

By

Christina Bennett, MS

Publish Date May 13, 2021

Early radiotherapy may preserve visual acuity for certain children with sporadic optic pathway/hypothalamic gliomas.

Extended Induction Chemotherapy Does Not Improve Survival in High-Risk Neuroblastoma

By

Colby Stong

Publish Date April 23, 2021

Researchers found that the therapy did not improve EFS or OS in high-risk patients and also led to an increase in toxic side effects.

Novel Therapy for Diffuse Intrinsic Pontine Glioma Fast Tracked

By

Diana Ernst, RPh

Publish Date March 4, 2021

Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year.

American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends

By

Rachel Narozniak, MA

Publish Date February 4, 2021

The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.

Immunotherapy Improves Survival Despite Brain Metastases

By

Jody A. Charnow

Publish Date September 17, 2020

Immunotherapy improved median overall survival by 7.5 months regardless of what other treatments patients received.

Brain Cancer Clinical Trials

Underrepresentation of Women in Clinical Trials Persists

Clinical trials leading to US FDA approvals of anticancer therapies continue to underrepresent women.

Brain Cancer Treatment Regimens

View detailed drug regimens for the treatment of brain cancer, including treatments such as temozolomide, carboplatin, and methotrexate.

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

[Cancer Management and Research] A review of past and ongoing trials using ipilimumab-nivolumab combination therapy for metastatic renal cell carcinoma.

Call for ‘Challenge Trials’ to Hasten COVID-19 Vaccine Development

Scientists say such ‘human challenge trials’ are of ‘vast importance’ in speeding up the testing of vaccines.

African-American Participation Inadequate in Cancer Drug Trials

Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types.